Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Zhaoke Ophthalmology Ltd. ( (HK:6622) ) just unveiled an update.
Zhaoke Ophthalmology Limited has announced its upcoming annual general meeting, scheduled for May 16, 2025, where shareholders will vote on resolutions to authorize the company’s directors to repurchase shares and issue additional shares or securities. These resolutions, if passed, will enable the company to manage its share capital more flexibly, potentially impacting its market positioning and shareholder value.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Limited is a company incorporated in the British Virgin Islands and continued in the Cayman Islands. It operates within the ophthalmology industry, focusing on developing and commercializing treatments for eye diseases. The company is listed on the Stock Exchange of Hong Kong.
YTD Price Performance: 38.33%
Average Trading Volume: 2,676,931
Technical Sentiment Signal: Buy
Current Market Cap: HK$846.5M
Learn more about 6622 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue